The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity
- PMID: 3669763
The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity
Abstract
The natural killer (NK) activity of peripheral blood mononuclear cells against K562 targets was variable in 10 untreated patients with hairy cell leukemia and was inversely related to the number of hairy cells (HCs) present. After therapy with alpha-interferon (IFN-alpha) NK activity in vitro was equivalent to that of normal controls. It is suggested that the low activity often seen before treatment is attributable to dilution of NK cells by large numbers of inactive HCs and that this diluting effect is reduced as HCs disappear from the blood during IFN-alpha treatment. HCs was consistently resistant to NK lysis by normal or hairy cell leukemia allogeneic and autologous mononuclear cells, despite whether effector or target cells had been pretreated with IFN-alpha. Cold-target inhibition and direct binding experiments showed that HCs do not bind to NK effectors. It is therefore concluded that NK cells play no direct role in the progressive disappearance of HCs seen in patients receiving IFN-alpha.
Similar articles
-
Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.Leukemia. 1988 Jun;2(6):377-81. Leukemia. 1988. PMID: 3374170
-
Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.Leukemia. 1989 May;3(5):373-9. Leukemia. 1989. PMID: 2497282
-
Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.Leukemia. 1987 Apr;1(4):377-9. Leukemia. 1987. PMID: 3499543
-
Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells.Leuk Lymphoma. 1994;14 Suppl 1:23-6. Leuk Lymphoma. 1994. PMID: 7820049 Review.
-
Interferons: current status and future directions of this prototypic biological.Springer Semin Immunopathol. 1986;9(1):73-83. doi: 10.1007/BF00201906. Springer Semin Immunopathol. 1986. PMID: 2425443 Review. No abstract available.
Cited by
-
Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.Cancer Immunol Immunother. 1991;34(2):115-22. doi: 10.1007/BF01741345. Cancer Immunol Immunother. 1991. PMID: 1760815 Free PMC article.
-
Cytokines: biological function and clinical use.J R Coll Physicians Lond. 1988 Oct;22(4):226-31. J R Coll Physicians Lond. 1988. PMID: 2466118 Free PMC article. No abstract available.
-
The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines.Cancer Immunol Immunother. 2009 May;58(5):665-75. doi: 10.1007/s00262-008-0588-0. Epub 2008 Oct 1. Cancer Immunol Immunother. 2009. PMID: 18828018 Free PMC article.
-
Hairy cells are not lysed by autologous LAK cells.Blut. 1989 Jan;58(1):49-50. doi: 10.1007/BF00320238. Blut. 1989. PMID: 2783868 No abstract available.
-
Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders.J Exp Med. 1990 Dec 1;172(6):1729-34. doi: 10.1084/jem.172.6.1729. J Exp Med. 1990. PMID: 2258703 Free PMC article.